Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to manufacture and sell its proprietary ...

Gilas Pilipinas is geared up and ready for the November window of the FIBA Asia Cup Qualifiers, with the Samahang Basketbol ...